Forecast of Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs 麻豆原创 Growth 2024

Publication ID:

PB24190355

Publication Date:

April 9, 2019

Pages:

135

Publisher:

MRRPB2

Countries:

Global [1]

USD 3,660.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market will register a 5.9% CAGR in terms of revenue, the market size will reach USD 96 Million by 2024, from USD 72 Million in 2019.

Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families.
The classification of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs includes 5-HT3 Inhibitors, NK1 Inhibitors and others. The proportion of 5-HT3 Inhibitors in 2017 is about 62%, and the proportion of NK1 Inhibitors in 2017 is about 33%.
Chemotherapy Induced Nausea and Vomiting (CINV) Drugs are application for Highly Emetogenic Chemotherapy, Moderately Emetogenic Chemotherapy, Low Emetogenic Chemotherapy and others. The most of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs is used for Moderately Emetogenic Chemotherapy, and the market share of that is about 52 % in 2017.

According to this study, over the next five years the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market will register a 5.9% CAGR in terms of revenue, the global market size will reach US$ 96 million by 2024, from US$ 72 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Chemotherapy Induced Nausea and Vomiting (CINV) Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market by product type, application, key manufacturers and key regions and countries.

This study considers the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
5-HT3 Inhibitors
NK1 Inhibitors
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Highly Emetogenic Chemotherapy
Moderately Emetogenic Chemotherapy
Low Emetogenic Chemotherapy
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Heron Therapeutics
Roche
Mylan
Tesaro

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market by identifying its various subsegments.
Focuses on the key global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hrs) post payment.

Table Of Contents:

Table of Contents

2019-2024 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption 麻豆原创 Report

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 麻豆原创 Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption 2014-2024
2.1.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption CAGR by Region
2.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Type
2.2.1 5-HT3 Inhibitors
2.2.2 NK1 Inhibitors
2.2.3 Other
2.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Type
2.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption 麻豆原创 Share by Type (2014-2019)
2.3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue and 麻豆原创 Share by Type (2014-2019)
2.3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Type (2014-2019)
2.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Application
2.4.1 Highly Emetogenic Chemotherapy
2.4.2 Moderately Emetogenic Chemotherapy
2.4.3 Low Emetogenic Chemotherapy
2.4.4 Other
2.5 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Application
2.5.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption 麻豆原创 Share by Application (2014-2019)
2.5.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value and 麻豆原创 Share by Application (2014-2019)
2.5.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Application (2014-2019)

3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Players
3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales 麻豆原创 Share by Players
3.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Players (2017-2019)
3.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales 麻豆原创 Share by Players (2017-2019)
3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue 麻豆原创 Share by Players
3.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Players (2017-2019)
3.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue 麻豆原创 Share by Players (2017-2019)
3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Players
3.4 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Regions
4.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Regions
4.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Regions
4.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value by Regions
4.2 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Growth
4.3 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Growth
4.4 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Growth
4.5 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Growth

5 Americas
5.1 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Countries
5.1.1 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Countries (2014-2019)
5.1.2 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value by Countries (2014-2019)
5.2 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Type
5.3 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Countries
6.1.1 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Countries (2014-2019)
6.1.2 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value by Countries (2014-2019)
6.2 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Type
6.3 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Countries
7.1.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Countries (2014-2019)
7.1.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value by Countries (2014-2019)
7.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Type
7.3 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Countries
8.1.1 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value by Countries (2014-2019)
8.2 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Type
8.3 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 麻豆原创 Challenges and Impact
9.3 麻豆原创 Trends

10 麻豆原创ing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors
10.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Customer

11 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs 麻豆原创 Forecast
11.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2019-2024)
11.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Forecast by Regions
11.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Forecast by Regions (2019-2024)
11.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States 麻豆原创 Forecast
11.3.2 Canada 麻豆原创 Forecast
11.3.3 Mexico 麻豆原创 Forecast
11.3.4 Brazil 麻豆原创 Forecast
11.4 APAC Forecast by Countries
11.4.1 China 麻豆原创 Forecast
11.4.2 Japan 麻豆原创 Forecast
11.4.3 Korea 麻豆原创 Forecast
11.4.4 Southeast Asia 麻豆原创 Forecast
11.4.5 India 麻豆原创 Forecast
11.4.6 Australia 麻豆原创 Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany 麻豆原创 Forecast
11.5.2 France 麻豆原创 Forecast
11.5.3 UK 麻豆原创 Forecast
11.5.4 Italy 麻豆原创 Forecast
11.5.5 Russia 麻豆原创 Forecast
11.5.6 Spain 麻豆原创 Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt 麻豆原创 Forecast
11.6.2 South Africa 麻豆原创 Forecast
11.6.3 Israel 麻豆原创 Forecast
11.6.4 Turkey 麻豆原创 Forecast
11.6.5 GCC Countries 麻豆原创 Forecast
11.7 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Forecast by Type
11.8 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Forecast by Application

12 Key Players Analysis
12.1 Merck
12.1.1 Company Details
12.1.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
12.1.3 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Merck News
12.2 Eisai
12.2.1 Company Details
12.2.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
12.2.3 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Eisai News
12.3 Mundipharma
12.3.1 Company Details
12.3.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
12.3.3 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Mundipharma News
12.4 Qilu Pharma
12.4.1 Company Details
12.4.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
12.4.3 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Qilu Pharma News
12.5 Teva
12.5.1 Company Details
12.5.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
12.5.3 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Teva News
12.6 Novartis
12.6.1 Company Details
12.6.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
12.6.3 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Novartis News
12.7 Heron Therapeutics
12.7.1 Company Details
12.7.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
12.7.3 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Heron Therapeutics News
12.8 Roche
12.8.1 Company Details
12.8.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
12.8.3 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Roche News
12.9 Mylan
12.9.1 Company Details
12.9.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
12.9.3 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Mylan News
12.10 Tesaro
12.10.1 Company Details
12.10.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Offered
12.10.3 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Tesaro News

13 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.